CC
FATE icon

Centiva Capital’s Fate Therapeutics FATE Stock Holding History

Centiva Capital’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,885
Closed -$50.6K – 1941
2023
Q3 		$50.6K Sell
23,885
-201
-0.8% -$666 ﹤0.01% 1601
2023
Q2 		$115K Buy
+24,086
New +$133K 0.01% 1436
2021
Q3 		– Sell
-2,821
Closed -$245K – 1385
2021
Q2 		$245K Buy
+2,821
New +$227K 0.02% 1111
2020
Q3 		– Sell
-11,235
Closed -$385K – 759
2020
Q2 		$385K Buy
+11,235
New +$335K 0.09% 351

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return